P-Glycoprotein Turned Twenty: Are We Any Closer to Fight Drug Resistance in Cancer?

Publisher： Karger

E-ISSN： 2296-5262|23|4|316-317

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.23, Iss.4, 2000-09, pp. : 316-317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells

By Navarro Gemma   Sawant Rupa R   Biswas Swati   Essex Sean   Tros de Ilarduya Conchita   Torchilin Vladimir P  

Nanomedicine, Vol. 7, Iss. 1, 2012-01 ,pp. : 65-78

Future Medicine

Access to resources Recommend Favorite

Determination and Prediction of P-Glycoprotein and Multidrug-Resistance-Related Protein Expression in Breast Cancer with Double-Phase Technetium-99m Sestamibi Scintimammography

By  

Oncology, Vol. 70, Iss. 6, 2007-02 ,pp. : 403-410

Karger

Access to resources Recommend Favorite

Effects of Rolapitant Administered Intravenously or Orally on the Pharmacokinetics of Digoxin (P‐glycoprotein Substrate) and Sulfasalazine (Breast Cancer Resistance Protein Substrate) in Healthy Volunteers

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 58, Iss. 2, 2018-02 ,pp. : 202-211

John Wiley & Sons Inc

Access to resources Recommend Favorite

The need for an objective measure in septorhinoplasty surgery: are we any closer to finding an answer?

By  

CLINICAL OTOLARYNGOLOGY, Vol. 40, Iss. 6, 2015-12 ,pp. : 698-703

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P‐glycoprotein and enhancing apoptosis

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 8, 2015-10 ,pp. : 2029-2039

John Wiley & Sons Inc

Access to resources Recommend Favorite